DRKS00031836已完成不适用
Virus Allianz NRW Standort Bonn Study - VIRABO
Institut für Virologie/Universitätsklinikum Bonn0 个研究点目标入组 675 人开始时间: 2023年8月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 675
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •Consenting residents of Heinsberg or Rheinbach and prior participation in at least one of the two studies DRKS00021306 or DRKS00023113 or random selection by the local government based on resident data.
排除标准
- •(i) Refusal of informed consent.
- •(ii) Contraindication to the selected specimen collection methods (venipuncture or capillary blood collection via fingertip or throat swab).
研究者
相似试验
招募中
不适用
Human Epidemiology of Newly Identified ArbovirusesArbovirus InfectionsSARS-CoV InfectionNCT04954352University Hospital, Montpellier400
招募中
不适用
REspiratory Syncytial virus Consortium in EUrope (RESCEU) study: Defining the burden of disease of Respiratory Syncytial Virus in Europe.COVID-19RSV-bronchiolitisRSV-infectionSARS-CoV-21004743810024970NL-OMON52977niversity Medical Center Utrecht2,500
招募中
不适用
REspiratory Syncytial virus Consortium in EUrope (RESCEU): Presumed risk factors and biomarkers for RSV-related severe disease and related sequelae.NL-OMON52425niversity Medical Center Utrecht160
已完成
不适用
Travel-Imported Arbovirus infections and mHealth applications for outbreak Risk Assessment: ZIeKA monitor part 2NL-OMON48637RIVM239
进行中（未招募）
1 期
Clinical trial for the treatment of COVID-19 and COVID-like illness in primary careCOVID-19, COVID-like-illnessMedDRA version: 21.1Level: PTClassification code: 10068724Term: Antiviral treatment Class: 100000004865CTIS2022-501707-27-01niversity Medical Center Utrecht1,001